Toxys
VerifiedProvides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development
Launch date
Employees
Ownership
Firm valuation
$9—13m (Dealroom.co estimates Mar 2020.)
Leiden South Holland (HQ)
RELATED LANDSCAPES AND LISTS
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| N/A | Grant | ||
| N/A | Early VC | ||
| €50k | Grant | ||
* | €2m | Late VC | |
| Total Funding | $2.3m | ||
Recent News about Toxys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.